Annual report pursuant to Section 13 and 15(d)

Note 8 - Accrued Liabilities

v3.23.1
Note 8 - Accrued Liabilities
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities

 

Accrued liabilities consisted of the following (in thousands):

   

December 31, 2022

   

December 31, 2021

 

Accrued compensation

    667       484  

Accrued clinical trial costs

    472       284  

Accrued research and other professional fees

    215       191  

Accrued other liabilities

    11       7  

Total accrued liabilities

  $ 1,365     $ 966